HJ-Investment

Overview

HJ-Investment is a Chinese private equity firm specializing in biomedical and information technology sectors. Established in 2015 and headquartered in Hangzhou, Zhejiang, China, the firm focuses on institutional investments in these industries. The assets of the firm are managed and governed by an executive management team. The firm's investment strategy includes direct investments, corporate loans, and asset management services. HJ-Investment has completed numerous direct investments across different sectors, with a portfolio spanning financial services, construction, clean energy, biotechnology, automotive, oil & gas, hospitality, and real estate. The firm partners with high-quality management teams to build long-term value by driving growth, operational improvements, and market expansion. HJ-Investment has participated in transactions exceeding US$1.7 billion. The firm emphasizes sustainability, risk management, and value creation for both investors and borrowers. It adheres strictly to capital adequacy and reporting standards mandated by the authorities, ensuring transparency, accountability, and long-term financial stability. The firm's authorized signatories maintain sole authority in accordance with its registration with the Ministry of Industry and Commerce.